Evolus, Inc. (EOLS) vs Sight Sciences, Inc. (SGHT)
A side-by-side comparison of Evolus, Inc. and Sight Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EOLS
Evolus, Inc.
$7.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SGHT
Sight Sciences, Inc.
$8.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EOLS vs SGHT
growth of $100 · dividends reinvested · last 5yEOLS -38.2% (-9.2%/yr)SGHT -73.4% (-23.3%/yr)EOLS compounded faster over this window
EOLS SGHT
EOLS vs SGHT: by the numbers
- •EOLS is the larger company ($486M vs $466M market cap).
- •Both run net losses; EOLS's is the smaller (-10.85% vs -35.69% net margin).
- •EOLS grew revenue faster over the past five years (32.82% vs 16.53% CAGR).
Metrics side by side
Valuation
| Metric | EOLS | SGHT |
|---|---|---|
| P/S ratio | 1.54 | 5.59 |
| P/B ratio | N/A | 8.81 |
Profitability
| Metric | EOLS | SGHT |
|---|---|---|
| Gross margin | 66.25% | 87.96% |
| Operating margin | -7.33% | -47.95% |
| Net margin | -10.85% | -35.69% |
| ROE | N/A | -56.26% |
| ROIC | -15.54% | -29.50% |
Growth (annualized)
| Metric | EOLS | SGHT |
|---|---|---|
| Revenue CAGR (5Y) | 32.82% | 16.53% |
| Total return CAGR (5Y) | 0.46% | -18.69% |
Frequently asked
- Which has grown faster, EOLS or SGHT?
- Over the past five years, EOLS grew revenue faster — EOLS at a 32.82% CAGR versus SGHT at 16.53%.
- How have EOLS and SGHT total returns compared?
- Over the past 5 years, EOLS delivered 0.46% and SGHT delivered -18.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Evolus ROESight Sciences ROEEvolus operating marginSight Sciences operating marginEvolus revenue growthSight Sciences revenue growthEvolus free cash flowSight Sciences free cash flow
Evolus & Sight Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.